Exactly @TerriableTadpole that is my take too. The announcement States "published" not "peer reviewed" so one has to assume that the manuscript could be published in as little as a couple of weeks. "
"Investigators from the Carrick Institute have commenced compiling and analysing the data from the study in preparation for submission of their findings for publication." Once the publication has been released an announcement can then be processed and lodged with the ASX. Moreover lodgement will then take place for the findings to be peer reviewed and announced around Q2 2018! (e.g. page 16 of the latest investor presentation - Frontiers of Neurology) Interestingly once the information is published and then sent over for peer reviewing processes the turnaround time is actually on average 90 days. For a publication in Frontiers of Neurology)
https://www.frontiersin.org/about/review-system
If you use RAP as an example (although still 6 months away to get to this stage) - according to they're CEO Tony Keating their turnaround time to publish results is only around 1 week. I know it's a completely different study but they're going through a very similar process: Enrolling, analysing and compiling the results for US FDA approval to be published...
I can't see why this is going to be any different for NTI.
To be honest I think the people who sold NTI yesterday do not understand or realise that an announcement could still be imminent... IMO much better off buying more down here or just simply holding out waiting for the news to hit because when it does IMO it's going to be party time!
Cheers
Red bar
- Forums
- ASX - By Stock
- anticipated results
Exactly @TerriableTadpole that is my take too. The announcement...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.9¢ |
Change
0.002(2.99%) |
Mkt cap ! $64.55M |
Open | High | Low | Value | Volume |
6.7¢ | 7.2¢ | 6.7¢ | $45.29K | 648.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 684701 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 589299 | 0.070 |
1 | 36231 | 0.069 |
5 | 240000 | 0.068 |
2 | 255000 | 0.067 |
3 | 262000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 100000 | 1 |
0.074 | 40000 | 1 |
0.075 | 738582 | 2 |
0.076 | 90000 | 1 |
0.077 | 190000 | 3 |
Last trade - 15.37pm 22/11/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online